Zobrazeno 1 - 10 of 85 pro vyhledávání: '"D, Paillotin"'
1
Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)
Autor: D. Paillotin, A. Chajara, Gilles Robinet, Henri Berard, Radj Gervais, J. Hureaux, Fabrice Barlesi, Isabelle Monnet, S. Bota, Hervé Lena
Publikováno v: Annals of Oncology. 22:2466-2470
Background Brain metastases (BM) occur in up to 40% of non-small-cell lung cancer (NSCLC) patients. This trial assessed the safety and efficacy of pemetrexed–cisplatin in this population. Patients and methods Chemonaive NSCLC patients with BM ineli
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f7b5c4e683795c97f1c2e74a6f5c2ba
https://doi.org/10.1093/annonc/mdr003
Zobrazit plný text záznamu
2
Syndrome sclérodermiforme paranéoplasique
Autor: D. Paillotin, I. Marie, A. Hounkpati, J.-F. Muir, Antoine Cuvelier
Publikováno v: Revue des Maladies Respiratoires. 27:251-256
Resume Introduction En depit de la frequence de l’association sclerodermie et cancer, les classifications actuelles des sclerodermies systemiques distinguent mal les syndromes sclerodermiformes paraneoplasiques ou secondaires aux traitements antimi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eedf45699b7b28f6d90d7cabb013503a
https://doi.org/10.1016/j.rmr.2009.09.005
Zobrazit plný text záznamu
3
Étude de phase 2, randomisée, évaluant une polychimiothérapie orale (CCNU, Cyclophosphamide, étoposide) et une polychimiothérapie intraveineuse dans les cancers bronchiques à petites cellules en seconde ligne en rechute (essai GFPC0501)
Autor: D. Paillotin, Christos Chouaid, Radj Gervais, H. Le Caer, Y. Le Guen
Publikováno v: Revue des Maladies Respiratoires. 24:653-658
Resume Etat des connaissances Le pronostic des cancers bronchopulmonaires a petites cellules (CPC) en rechute est toujours reserve. Il n’y a pas de traitement de reference dans cette situation et une attention particuliere doit etre portee a la qua
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::31e5b32d0d0e1efaf65eaa760b26b736
https://doi.org/10.1016/s0761-8425(07)91136-5
Zobrazit plný text záznamu
4
Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 02-01
Autor: L. Gérinière, Jean-Pierre Daurès, G. Robinet, E. Jonveaux, S. Bota, R. Gervais, Hervé Le Caer, J. Mandet, L. Falchero, L. Thiberville, J. Créquit, S. Ramdane, R. Poirier, D. Coetmeur, B. Lamezec, G.M. Jung, S. Schouabe, O. Gallocher, P. Clavére, P. Fournel, E. Touboul, A. Vergnenégre, A. D'Hombres, B. Kin, F. Mornex, Christos Chouaid, Pierre-Jean Souquet, F. Blanchon, Marie-Cécile Bozonnat, J.N. Talabard, A. Rivière, Isabelle Martel-Lafay, B. Mennecier, M. Perol, P.J. Souquet, A. Lavolé, S. Bayle, F. Barlesi, T. Pignon, Pierre Fournel, H. Le Caer, J.P. Labat, A. Vergnenegre, E. Tessier, C. Gimenez, H. Léna, P. Thomas, P. Barre, G. Zalcman, D. Perdu, Y. Coscas, J.C. Pietra, P. Martin, D. Lerouge, D. Herman, J.Y. Delhoume, J. M. Chavaillon, B. Melloni, J.M. Chavaillon, R. Trouette, M. Benchalal, D. Arpin, C. Decroisette, B. Milleron, I. Martel-Lafay, A. Cauchois, H. Ramos, A. Roquette, J. Letreut, H. Berard, D. Paillotin, A. Ducolone, J.M. Vernejoux, P. Verrelle, J.C. Bout, J.P. Suchaud, H. Janicot, Radj Gervais, A. Zribi, A. Benyoub, V. Grangeon, Gilles Robinet, C. Bonnamour, M. Grivaux, C. Chouaid, E. Quoix, C. Belleguic, P. Merle, E. Dansin, M.A. Zawadi, Hervé Lena, J.B. Auliac
Publikováno v: European journal of cancer (Oxford, England : 1990). 52
Purpose The objective of this randomised phase II study was to evaluate the impact in terms of response and toxicities of induction or consolidation chemotherapy respectively before or after concurrent chemoradiotherapy in unresectable stage III non-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48c9d797d0faa9067c8980c03eb2f3c6
https://pubmed.ncbi.nlm.nih.gov/26689864
Zobrazit plný text záznamu
5
Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer
Autor: Gilles Robinet, Catherine Daniel, Maurice Pérol, D. Paillotin, A. Vergnenegre, E. Bouchaert, Jacques Letreut, Jean-Pierre Kleisbauer, Pierre Fournel, Hervé Lena, Pierre-Marie Preux, H. Le Caer
Publikováno v: Lung Cancer. 47:395-404
Summary Context: The most satisfactory treatment for patients with locally advanced non-small-cell lung cancer (NSCLC) is combination chemotherapy–radiotherapy (CT–RT). The optimal treatment modalities remain to be determined. Objective: We condu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ce7f50ab0e2b38c77b71a8b767b6d9b4
https://doi.org/10.1016/j.lungcan.2004.08.010
Zobrazit plný text záznamu
7
Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy
Autor: J.R. Barriere, Gilles Robinet, Jean-Pierre Kleisbauer, T Pignon, D. Paillotin, A Vernenegre, F. Bonnaud, J Clavier, Pascal Thomas, R. Poirier, P. Pommier de Santi, A. Taytard
Publikováno v: Lung Cancer. 18:71-81
A Phase I trial of carboplatin therapy was performed on patients with locally advanced non-small cell lung cancer who had been previously treated with cisplatin, mitomycin and a vinca alkaloid. This was administered as a daily bolus infusion or as a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9fd9e09a7b2232d52730e5418cbeb816
https://doi.org/10.1016/s0169-5002(97)00047-0
Zobrazit plný text záznamu
8
Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer
Autor: Guérin Jc, Alain Vergnenegre, Gilles Robinet, Pascal Thomas, M. Grivaux, Jean-Pierre Kleisbauer, P. Carles, P. Balmes, D. Paillotin, Maurice Pérol, D Touron, R. Poirier, E. Pham
Publikováno v: Lung Cancer. 14:119-134
The study was designed to evaluate the value of vinorelbine in a cisplatin-mitomycin-vinca alkaloid regimen for treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC). A group of 227 patients with inoperable NSCLC in stage III
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::939357cb1b41452db68947b61a13693e
https://doi.org/10.1016/0169-5002(95)00517-x
Zobrazit plný text záznamu
10
[Paraneoplastic sclerodermiform syndrome]
Autor: A, Hounkpati, I, Marie, D, Paillotin, J-F, Muir, A, Cuvelier
Publikováno v: Revue des maladies respiratoires. 27(3)
Despite the known association between scleroderma and cancer, the current systemic sclerosis classifications do not clearly identify paraneoplastic sclerodermiform syndrome or sclerodermiform syndrome secondary to cancer treatments.A 56 year old man
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ba609e3dd60421ee766e4b2f3e138615
https://pubmed.ncbi.nlm.nih.gov/20359618
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje